Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

Research into topiramate to remove the hidden HIV in people living with HIV taking HIV treatment Recruiting

2024-511532-27-00 human immunodeficiency virus 1 (HIV-1) 2024-07-07
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator … Recruiting

2023-508024-36-00 Cardiogenic Shock 2024-07-05
Talazoparib plus Enzalutamide after progression to prior ARPi in Metastatic Prostate Cancer Recruiting

2023-510536-37-00 Prostate Cancer 2024-07-05
A study evaluating the safety and efficacy of an experimental drug for chronic lung disease against normally prescribed care in extremely pr… Recruiting

2024-515914-41-00 Chronic Lung Disease 2024-07-05
N-PLUS Recruiting

2022-502559-69-01 advanced (FIGO stage IIIA, IIIB, IIIC, or IV of the 201 2024-07-04
FAPI-PET imaging in solid tumors Recruiting

2024-514967-25-00 Cancer 2024-07-03
LONGITUDINAL STUDY OF THE POSITRON EMISSION TOMOGRAPHY (PET) TRACER FOR TAU 18F-PI-2620 IN INDIVIDUALS WITH DOWN SYNDROME Recruiting

2024-515574-27-00 Down Syndrome 2024-07-03
CBD-OH - Cannabidiol as an add-on treatment during inpatient alcohol cessation in patients with severe alcohol use disorder: a Phase II tria… Recruiting

2024-518455-28-00 Patients with severe Alcohol Use Disorder (according to 2024-07-03
Longitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD Study) Recruiting

2023-510508-31-01 cognitive impairment 2024-07-01
Azithromycin for treatment of hospitalized children with asthmatic symptoms Recruiting

2024-512605-29-01 Childhood asthma 2024-07-01
A Study Evaluating the Efficacy and Safety of Povorcitinib (INCB054707) in Adults With Inadequately Controlled Moderate to Severe Asthma Recruiting

2022-502570-16-01 Treatment of patients with inadequately controlled mode 2024-06-27
Single-blind randomized clinical trial in premature infants with Respiratory Distress Syndrome (RDS) eligible for treatment with exogenous s… Recruiting

2024-515641-42-00 Premature infants with Respiratory Distress Syndrome (R 2024-06-26
A Phase 2 Study to Evaluate MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease Recruiting

2023-508158-24-00 Moderately to Severely Active Crohn’s Disease 2024-06-25
Evaluation of the safety of inhaled sedation with Isoflurane in head trauma patients. Recruiting

2023-505729-15-00 Head trauma patient 2024-06-20
Effects by botulinum toxin in patients with jaw muscle pain Recruiting

2024-514739-12-00 Myogenous temporomandibular disorders (TMDM) 2024-06-20
PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma Recruiting

2022-501993-21-00 Dedifferentiated Liposarcoma 2024-06-20
Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomogra… Recruiting

2024-514587-44-00 Aortic stenosis 2024-06-17
PARACHUTES: Pedophilia At Risk – Acute Treatment – E-therapy vs SSRI Recruiting

2024-513388-16-00 Pedophilic disorder 2024-06-17
CARMOD - Golcadomide (BMS-986369) post-CAR T-cell in R/R Aggressive large B-cell lymphoma patients with high risk of relapse Recruiting

2023-506705-20-00 relapsed or refractory patients with aggressive large B 2024-06-14
FIRST-NEC - A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab (MEDI 4736) with etoposide and … Recruiting

2023-506590-35-00 Large-Cell NeuroEndocrine Carcinoma of the lung 2024-06-13
"Abdominal Aortic Aneurysm Stabilization with mesenchymal stem Cells" Recruiting

2022-501935-18-00 Patients with abdominal aortic aneurysm undergoing endo 2024-06-12
NOvel Immunotherapy strategies for advanced Triple negative breast Cancer (TNBC) patients: TONIC-3 trial Recruiting

2023-507875-23-00 advanced TNBC, eg. irresectable recurrent disease or m 2024-06-12
PreVent-ACaLL Recruiting

2024-511072-33-00 Chronic Lymphocytic Leukemia 2024-06-12
A Placebo-Controlled, Randomized Double-Blind Parallel Group 12-Month Trial of Fasudil for the Treatment of Early Alzheimer’s Disease Recruiting

2023-506514-44-00 Alzheimer's disease 2024-06-11